NM_000500.9:c.922T>G
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM1PM2PP2PP3_StrongPP5
The NM_000500.9(CYP21A2):c.922T>G(p.Leu308Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,460,544 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000500.9 missense
Scores
Clinical Significance
Conservation
Publications
- classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Myriad Women’s Health, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
- classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting formInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing formInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CYP21A2 | NM_000500.9 | c.922T>G | p.Leu308Val | missense_variant | Exon 7 of 10 | ENST00000644719.2 | NP_000491.4 | |
| CYP21A2 | NM_001128590.4 | c.832T>G | p.Leu278Val | missense_variant | Exon 6 of 9 | NP_001122062.3 | ||
| CYP21A2 | NM_001368143.2 | c.517T>G | p.Leu173Val | missense_variant | Exon 7 of 10 | NP_001355072.1 | ||
| CYP21A2 | NM_001368144.2 | c.517T>G | p.Leu173Val | missense_variant | Exon 6 of 9 | NP_001355073.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CYP21A2 | ENST00000644719.2 | c.922T>G | p.Leu308Val | missense_variant | Exon 7 of 10 | NM_000500.9 | ENSP00000496625.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.0000162 AC: 4AN: 246400 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1460544Hom.: 0 Cov.: 38 AF XY: 0.00 AC XY: 0AN XY: 726596 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:1
not specified Uncertain:1
Variant summary: CYP21A2 c.922T>G (p.Leu308Val) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.6e-05 in 246400 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.922T>G has been reported in the literature in individuals affected with Congenital Adrenal Hyperplasia (CAH), including at least one individual with simple virilizing CAH (e.g., Sarafoglou_Pediatrics_2012, Sarafoglou_JAMA_2012) and at least two individuals with non-classic CAH (e.g., New_2013, Bruque_2013, Wan_2023). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 27966633, 23359698, 23071209, 36167262, 22692165). One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at